Literature DB >> 6317884

Effects of ATP and inhibitory factors on the activity of vaccinia virus type I topoisomerase.

P D Foglesong, W R Bauer.   

Abstract

Vaccinia virus cores contain a type I topoisomerase which promotes the relaxation of superhelical DNA of either handedness (Bauer et al., Proc. Natl. Acad. Sci. U.S.A. 74:1841-1845, 1977). The activity of partially purified vaccinia virus topoisomerase (VV-Topo I) was determined in the presence of ATP, dATP, GTP, ADP, and ATP analogs in which hydrolysis of the alpha, beta or beta, gamma phosphate bond is restricted. Topoisomerase activity was stimulated 2.5-fold by the addition of 2 to 4 mM ATP or dATP to standard assay mixtures; 2 mM GTP produced no significant effect on enzyme activity. The addition of 2 mM beta, gamma-imido ATP or 2 mM gamma-thiophosphate ATP reduced VV-Topo I activity by 80 and 65%, respectively. In contrast, 4 mM alpha, beta-methylene ATP produced no significant change in topoisomerase activity compared to ATP itself. Assays performed in the presence of 4 mM ADP exhibited an 80% reduction in enzyme activity. The preparations of VV-Topo I used for these studies showed, however, no detectable DNA-dependent or -independent ATPase activity. The activity of VV-Topo I was similarly measured in the presence of the antibiotics novobiocin and coumermycin A1, which inhibited enzyme activity by 50% at concentrations of 180 and 40 microM, respectively. Comparable inhibition of VV-Topo I activity was observed in the presence of 1 mM beta, gamma-imido ATP. We determined that novobiocin inhibits vaccinia core transcription at the same concentrations which inhibit vaccinia core topoisomerase I activity. These results suggest that the vaccinia DNA topoisomerase may play a role in the ATP-dependent transcription of viral genes from intact core particles.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6317884      PMCID: PMC255417     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Further characterization of deoxyribonucleases from vaccinia virus.

Authors:  B G Pogo; M T O'shea
Journal:  Virology       Date:  1977-03       Impact factor: 3.616

2.  DNA supercoiling by Xenopus laevis oocyte extracts: requirement for a nuclear factor.

Authors:  M I Baldi; E Mattoccia; G P Tocchini-Valentini
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

3.  Poxvirus DNA-dependent RNA polymerase.

Authors:  J R Kates; B R McAuslan
Journal:  Proc Natl Acad Sci U S A       Date:  1967-07       Impact factor: 11.205

4.  RNA polymerase activity in purified infectious vaccinia virus.

Authors:  W Munyon; E Paoletti; J T Grace
Journal:  Proc Natl Acad Sci U S A       Date:  1967-12       Impact factor: 11.205

5.  A DNA nicking-closing enzyme encapsidated in vaccinia virus: partial purification and properties.

Authors:  W R Bauer; E C Ressner; J Kates; J V Patzke
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

6.  Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions.

Authors:  S A Martin; E Paoletti; B Moss
Journal:  J Biol Chem       Date:  1975-12-25       Impact factor: 5.157

7.  Vaccinia virus replication. I. Requirement for the host-cell nucleus.

Authors:  D E Hruby; L A Guarino; J R Kates
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

8.  Purification of mRNA guanylyltransferase from vaccinia virions.

Authors:  G Monroy; E Spencer; J Hurwitz
Journal:  J Biol Chem       Date:  1978-06-25       Impact factor: 5.157

9.  Multiple roles for ATP in the synthesis and processing of mRNA by vaccinia virus: specific inhibitory effects of adenosine (beta,gamma-imido) triphosphate.

Authors:  A Gershowitz; R F Boone; B Moss
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

10.  Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.

Authors:  M Gellert; K Mizuuchi; M H O'Dea; T Itoh; J I Tomizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

View more
  19 in total

1.  Identification of a vaccinia virus gene encoding a type I DNA topoisomerase.

Authors:  S Shuman; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Sedimentation of an RNA polymerase complex from vaccinia virus that specifically initiates and terminates transcription.

Authors:  S S Broyles; B Moss
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

3.  Molecular genetic analysis of a vaccinia virus gene with an essential role in DNA replication.

Authors:  E Evans; P Traktman
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  Type I topoisomerase activity after infection of enucleated, synchronized mouse L cells by vaccinia virus.

Authors:  S K Poddar; W R Bauer
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

5.  A vaccinia virus DNase preparation which cross-links superhelical DNA.

Authors:  N Lakritz; P D Foglesong; M Reddy; S Baum; J Hurwitz; W R Bauer
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

6.  In vitro transcription of a cloned vaccinia virus gene by a soluble extract prepared from vaccinia virus-infected HeLa cells.

Authors:  P D Foglesong
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

7.  Molecular genetic analysis of vaccinia virus DNA polymerase mutants.

Authors:  P Traktman; M Kelvin; S Pacheco
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

8.  Novobiocin and coumermycin A1 inhibit viral replication and the reactivation of herpes simplex virus type 1 from the trigeminal ganglia of latently infected mice.

Authors:  J G Spivack; D R O'Boyle; N W Fraser
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

9.  A soluble transcription system derived from purified vaccinia virions.

Authors:  F Golini; J R Kates
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

10.  Increased ATP generation in the host cell is required for efficient vaccinia virus production.

Authors:  Chia-Wei Chang; Hui-Chun Li; Che-Fang Hsu; Chiao-Yen Chang; Shih-Yen Lo
Journal:  J Biomed Sci       Date:  2009-09-02       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.